Dr. Bunnell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Avenue
Dana Farber Cancer Institute
Boston, MA 02215Phone+1 617-632-5024Fax+1 617-582-7328
Education & Training
Massachusetts Institute of TechnologyMBA, Business/Management, 2006 - 2008
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1993 - 1996- Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1993
- Brigham and Women's HospitalInternship, Internal Medicine, 1990 - 1991
Harvard School of Public HealthMPH, 1988 - 1990
Harvard Medical SchoolClass of 1989, MD
Certifications & Licensure
MA State Medical License 1992 - 2025
ME State Medical License 2022 - 2024- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer Start of enrollment: 2004 Jan 01
- Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer Start of enrollment: 2005 Oct 01
- Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer Start of enrollment: 2002 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsEarly Findings on the Use of Clinical Pathways for Management of Unwarranted Variation in Cancer Care.David M. Jackman, Emily Foster, Joanna M. Hamilton, Carole Kathleen Tremonti, Craig A. Bunnell
American Journal of Medical Quality. 2021-06-08 - 19 citationsPhase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer.Filipa Lynce, James T. Williams, Meredith M. Regan, Craig A. Bunnell, Rachel A. Freedman
Cancer Chemotherapy and Pharmacology. 2021-02-14 - 58 citationsEfficacy of Pegfilgrastim and Darbepoetin Alfa As Hematopoietic Support for Dose-Dense Every-2-Week Adjuvant Breast Cancer ChemotherapyHarold J. Burstein, Leroy M. Parker, Aparna Keshaviah, Jennifer A. Doherty, Ann H. Partridge
Journal of Clinical Oncology. 2005-11-20
Press Mentions
Dana-Farber, Brigham Split Creates New Opportunities for Cancer CareNovember 1st, 2024- Late Stage Cancer Rates Could Rise if ACA Ruling Stands, Experts WorryMarch 31st, 2023
- Dana-Farber Brigham Cancer Center Opens New Facility in FoxboroughAugust 10th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
